D2Y-22420-42577
4 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 871 / NM
- Registered
- 2022-10-05
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Dose 2 — Pfizer-BioNTech
-
2021-11-06
Dose 3 — Moderna
-
2022-10-05
Registered in v-safe
-
2022-10-05
Dose 4 — Moderna
-
2022-10-05
Survey response — day 0, dose 4MedDRA: Dizziness — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-07
- 2022-10-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | No |
| 2 | 2021-03-30 | Pfizer-BioNTech | No |
| 3 | 2021-11-06 | Moderna | No |
| 4 | 2022-10-05 | Moderna | No |
Free text
Release 12 — day 0, dose 4
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release